In a recent large prospective study, vasectomy was associated with modestly higher risk of prostate cancer, especially high-grade and lethal prostate cancer. However, evidence from prospective studies ...
Advaxis expects to announce the next steps for ADXS-PSA by 1st half of 2020, being used to treat patients with prostate cancer in combination with Keytruda which is partnered with Merck. ADXS-503 ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback